These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 10447421)

  • 1. Status of long-term asymptomatic HIV-1 infection correlates with viral load but not with virus replication properties and cell tropism. French ALT Study Group.
    Candotti D; Costagliola D; Joberty C; Bonduelle O; Rouzioux C; Autran B; Agut H
    J Med Virol; 1999 Jul; 58(3):256-63. PubMed ID: 10447421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
    Hoen B; Cooper DA; Lampe FC; Perrin L; Clumeck N; Phillips AN; Goh LE; Lindback S; Sereni D; Gazzard B; Montaner J; Stellbrink HJ; Lazzarin A; Ponscarme D; Staszewski S; Mathiesen L; Smith D; Finlayson R; Weber R; Wegmann L; Janossy G; Kinloch-de Loes S;
    Clin Infect Dis; 2007 Aug; 45(3):381-90. PubMed ID: 17599319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of GBV-C infection in HIV-1 infected patients.
    Canducci F; Uberti Foppa C; Boeri E; Racca S; Gallotta G; Grasso MA; Calori G; Lazzarin A; Clementi M
    J Biol Regul Homeost Agents; 2003; 17(2):191-4. PubMed ID: 14518722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
    Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
    AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effector HIV-specific cytotoxic T-lymphocyte activity in long-term nonprogressors: associations with viral replication and progression.
    Keoshkerian E; Ashton LJ; Smith DG; Ziegler JB; Kaldor JM; Cooper DA; Stewart GJ; Ffrench RA
    J Med Virol; 2003 Dec; 71(4):483-91. PubMed ID: 14556259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms involved in the low-level regeneration of CD4+ cells in HIV-1-infected patients receiving highly active antiretroviral therapy who have prolonged undetectable plasma viral loads.
    Benveniste O; Flahault A; Rollot F; Elbim C; Estaquier J; Pédron B; Duval X; Dereuddre-Bosquet N; Clayette P; Sterkers G; Simon A; Ameisen JC; Leport C
    J Infect Dis; 2005 May; 191(10):1670-9. PubMed ID: 15838794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended antiretroviral treatment interruption in HIV-infected patients with long-term suppression of plasma HIV RNA.
    Achenbach CJ; Till M; Palella FJ; Knoll MD; Terp SM; Kalnins AU; Murphy RL
    HIV Med; 2005 Jan; 6(1):7-12. PubMed ID: 15670246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nef alleles from human immunodeficiency virus type 1-infected long-term-nonprogressor hemophiliacs with or without late disease progression are defective in enhancing virus replication and CD4 down-regulation.
    Crotti A; Neri F; Corti D; Ghezzi S; Heltai S; Baur A; Poli G; Santagostino E; Vicenzi E
    J Virol; 2006 Nov; 80(21):10663-74. PubMed ID: 16943296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and quantification of proviral HIV-1 184 M/V in circulating CD4(+) T cells of patients on HAART with a viremia less than 1,000 copies/ml.
    Mohey R; Jørgensen LB; Møller BK; Black FT; Kjems J; Obel N
    J Clin Virol; 2005 Dec; 34(4):257-67. PubMed ID: 16286049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy.
    Smith CJ; Sabin CA; Youle MS; Kinloch-de Loes S; Lampe FC; Madge S; Cropley I; Johnson MA; Phillips AN
    J Infect Dis; 2004 Nov; 190(10):1860-8. PubMed ID: 15499544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal microangiopathy in human immunodeficiency virus infection is related to higher human immunodeficiency virus-1 load in plasma.
    Furrer H; Barloggio A; Egger M; Garweg JG;
    Ophthalmology; 2003 Feb; 110(2):432-6. PubMed ID: 12578793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rapid and slow progression of the infection by the type 1 human immunodeficiency virus in a population of seropositive subjects in Madrid].
    Soriano V; Martín R; del Romero J; Castilla J; Bru F; Bravo R; Gutiérrez M; Martínez P; Valencia E; García S; Mas A; Moreno V; Laguna F; Rodríguez C; Sabín ML; González-Lahoz J
    Med Clin (Barc); 1996 Dec; 107(20):761-6. PubMed ID: 9019602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of antiretroviral therapy and changes in virus load on human immunodeficiency virus (HIV)-specific T cell responses in primary HIV infection.
    Lacabaratz-Porret C; Urrutia A; Doisne JM; Goujard C; Deveau C; Dalod M; Meyer L; Rouzioux C; Delfraissy JF; Venet A; Sinet M
    J Infect Dis; 2003 Mar; 187(5):748-57. PubMed ID: 12599048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal quantification of human immunodeficiency virus type 1 DNA and RNA in long-term nonprogressors.
    Broström C; Visco-Comandini U; Yun Z; Sönnerborg A
    J Infect Dis; 1999 Jun; 179(6):1542-8. PubMed ID: 10228079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of the viral load and its use as a virological marker in the follow-up of HIV-1-positive patients].
    Hodara VL; Monticelli A; Benetucci J; Lasala M; Jauregui Rueda H; Libonatti O; García Messina O; Reboredo G; Bogdanowicz E; Bases O; Pampuro S; Salomón H
    Rev Argent Microbiol; 1998; 30(1):1-7. PubMed ID: 9629601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activation.
    Steel A; Cox AE; Shamji MH; John L; Nelson M; Henderson DC; Gotch FM; Gazzard BG; Kelleher P
    Antivir Ther; 2007; 12(6):971-5. PubMed ID: 17926652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steady increase in cellular HIV-1 load during the asymptomatic phase of untreated infection despite stable plasma viremia.
    Pasternak AO; Jurriaans S; Bakker M; Berkhout B; Lukashov VV
    AIDS; 2010 Jul; 24(11):1641-9. PubMed ID: 20543660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 DNA and RNA kinetics in primary HIV infection.
    Lillo F; Grasso M; Lodini S; Capiluppi B; Lazzarin A; Tambussi G
    J Biol Regul Homeost Agents; 2002; 16(1):49-52. PubMed ID: 12003174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.